| Market Cap | ₹478Cr |
| ROE | 18.04% |
| P/E Ratio(TTM) | 14.49 |
| EPS(TTM) | 74.77 |
| P/B Ratio | 2.61 |
| Dividend Yield | 1.66% |
| Industry P/E | 39.95 |
| Book Value | 414.39 |
| Debt to Equity | 0.01 |
| Face Value | 10 |
| Parent Organisation | Jenburkt Pharmaceuticals Limited |
| Managing Director | Ashish U. Bhuta |
| Founded | 1985 |
| BSE Symbol | 524731 |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Torrent Pharmaceuticals | NA (0.00%) | 59.98 | ||
| Ajanta Pharma | NA (0.00%) | 34.48 | ||
| Gland Pharma | NA (0.00%) | 34.39 | ||
| Eris Lifesciences | NA (0.00%) | 46.32 |